Name: AQST Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: AQST, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does AQST have?

Accepted Answer

Aquestive Therapeutics, Inc. (AQST) has 34 SEC Form 4 filings (46 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Aug 18, 2026.

Question 2

When was the most recent SEC Form 4 filing for AQST?

Accepted Answer

The most recent Form 4 filing for AQST on Tracefour is dated Aug 18, 2026.

Question 3

Who is the most active insider at AQST?

Accepted Answer

The most active SEC Form 4 filer at AQST in the rolling window is President and CEO Barber Daniel, with 7 filings.

Question 4

What is the net insider flow at AQST over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at AQST have net sold $2.0M based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at AQST in the current window?

Accepted Answer

Inside the rolling window, insiders at AQST bought $0 and sold $3.7M based on SEC Form 4 filings.

Question 6

Can I get alerts for AQST insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aquestive Therapeutics, Inc. (AQST). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Barber Daniel	President and CEO	Sale	25,000	$107K	Aug 18	SEC ↗
Barber Daniel	President and CEO	Sale	4,631	$19K	Jul 17	SEC ↗
Barber Daniel	President and CEO	Sale	20,369	$82K	Jul 17	SEC ↗
Krop JulieFirst filing	Director	Sale	25,000	$125K	Jun 24	SEC ↗
Barber Daniel	President and CEO	Sale	8,257	$35K	May 18	SEC ↗
BRAENDER LORI JFirst filing	Chief Legal Officer	Sale	40,102	$167K	Mar 11	SEC ↗
Boyd Peter E.First in 5 months	Chief People Officer	Sale	29,814	$124K	Mar 11	SEC ↗
Barber DanielFirst in 5 months	President and CEO	Sale	180,677	$754K	Mar 11	SEC ↗
Cioffi MelinaFirst filing	SVP, Regulatory Affairs	Sale	25,311	$106K	Mar 11	SEC ↗
TOTH A ERNEST JRFirst filing	Chief Financial Officer	Sale	58,254	$243K	Mar 11	SEC ↗
Jung CassieFirst in 5 months	Chief Operating Officer	Sale	45,791	$191K	Mar 11	SEC ↗
Korczynski SherryFirst filing	Chief Commercial Officer	Sale	15,741	$66K	Mar 11	SEC ↗
Jung Cassie	Chief Operating Officer	Sale	67,575	$474K	Oct 17	SEC ↗
Kraus Carl NFirst filing	Chief Medical Officer	Sale	20,272	$142K	Oct 17	SEC ↗
Boyd Peter E.	See Remarks	Sale	10,000	$70K	Oct 17	SEC ↗
Barber Daniel	President and CEO	Sale	91,343	$551K	Sep 29	SEC ↗
Boyd Peter E.	See Remarks	Sale	10,000	$63K	Sep 29	SEC ↗
Barber DanielFirst filing	President and CEO	Sale	400	$2K	Sep 22	SEC ↗
Jung CassieFirst filing	Chief Operating Officer	Sale	62,180	$311K	Sep 8	SEC ↗
Boyd Peter E.First filing	See Remarks	Sale	15,000	$80K	Sep 8	SEC ↗

AQST

Related companies